BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20193040)

  • 1. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
    Tian G; Kong Q; Lai L; Ray-Chaudhury A; Lin CL
    J Neurochem; 2010 May; 113(4):978-89. PubMed ID: 20193040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.
    Butchbach ME; Tian G; Guo H; Lin CL
    J Biol Chem; 2004 Aug; 279(33):34388-96. PubMed ID: 15187084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke.
    Hernández-Jiménez M; Martínez-López D; Gabandé-Rodríguez E; Martín-Segura A; Lizasoain I; Ledesma MD; Dotti CG; Moro MA
    Stroke; 2016 Jan; 47(1):206-13. PubMed ID: 26628388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke.
    Hurtado O; Pradillo JM; Fernández-López D; Morales JR; Sobrino T; Castillo J; Alborch E; Moro MA; Lizasoain I
    Neurobiol Dis; 2008 Jan; 29(1):123-31. PubMed ID: 17884513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells.
    Bogdanovic N; Bretillon L; Lund EG; Diczfalusy U; Lannfelt L; Winblad B; Russell DW; Björkhem I
    Neurosci Lett; 2001 Nov; 314(1-2):45-8. PubMed ID: 11698143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yes-associated protein regulates glutamate homeostasis through promoting the expression of excitatory amino acid transporter-2 in astrocytes via β-catenin signaling.
    Xu X; Wang J; Du S; Shen X; Lian J; Zhou J; Wang M; Feng W; Lv Z; Zhu J; Jin L; Sun H; Wu L; Wang X; Qiu H; Wang W; Teng H; Wang Y; Huang Z
    Glia; 2023 May; 71(5):1197-1216. PubMed ID: 36617748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyp46 polymorphisms in Alzheimer's disease: a review.
    Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
    J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.
    Wang Z; Pekarskaya O; Bencheikh M; Chao W; Gelbard HA; Ghorpade A; Rothstein JD; Volsky DJ
    Virology; 2003 Jul; 312(1):60-73. PubMed ID: 12890621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.
    Sharma A; Kazim SF; Larson CS; Ramakrishnan A; Gray JD; McEwen BS; Rosenberg PA; Shen L; Pereira AC
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21800-21811. PubMed ID: 31591195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression.
    Kim JM; Cha SH; Choi YR; Jou I; Joe EH; Park SM
    Sci Rep; 2016 Jun; 6():28823. PubMed ID: 27346864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.
    Lutgen V; Narasipura SD; Sharma A; Min S; Al-Harthi L
    J Neuroinflammation; 2016 Sep; 13(1):242. PubMed ID: 27612942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate transporter expression and function in human glial progenitors.
    Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
    Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity.
    Pajarillo E; Digman A; Nyarko-Danquah I; Son DS; Soliman KFA; Aschner M; Lee E
    J Biol Chem; 2021 Dec; 297(6):101372. PubMed ID: 34756885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.
    Kortagere S; Mortensen OV; Xia J; Lester W; Fang Y; Srikanth Y; Salvino JM; Fontana ACK
    ACS Chem Neurosci; 2018 Mar; 9(3):522-534. PubMed ID: 29140675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.
    Wu J; Lee MR; Choi S; Kim T; Choi DS
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1110-7. PubMed ID: 20374202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study.
    Banner SJ; Fray AE; Ince PG; Steward M; Cookson MR; Shaw PJ
    Neuroscience; 2002; 109(1):27-44. PubMed ID: 11784698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia.
    Weller ML; Stone IM; Goss A; Rau T; Rova C; Poulsen DJ
    Neuroscience; 2008 Sep; 155(4):1204-11. PubMed ID: 18620031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.